Lisocabtagene maraleucel for treating relapsed or refractory aggressive B-cell non-Hodgkin lymphoma (terminated appraisal)

Technology appraisal
Reference number: TA987
Published: 10 July 2024

Register as a stakeholder

History

Invitation to participate

Final stakeholder list (PDF 194 KB)

Published:

31 July 2020
Final scope (PDF 266 KB)

Published:

31 July 2020
NICE's response to comments on the draft scope and provisional stakeholder list (PDF 149 KB)

Published:

31 July 2020
Equality impact assessment (Scoping) (PDF 121 KB)

Published:

31 July 2020

Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators

Draft scope post referral (PDF 256 KB)

Published:

19 June 2020
Draft matrix of consultees and commentators post referral (PDF 194 KB)

Published:

19 June 2020

Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators

Draft scope post referral (PDF 220 KB)

Published:

05 June 2019
Draft matrix post referral (PDF 188 KB)

Published:

05 June 2019